MSD Turkey Contributed Cash & Vaccine Donation to Turkey’s Fight against COVID-19

MSD Turkey donated TRY 4.500.000 in total as cash donation valued at TRY 3.350.000 and 28.800 doses of pneumococcal vaccine to the Republic of Turkey Ministry of Health, General Directorate of Public Health to support the successful works by the Ministry in its fight against COVID-19 pandemic.

  • MSD announced the completion of the acquisition of Themis, a privately-held company focused on vaccines and immune-modulation therapies for infectious diseases and cancer. An initial focus of this agreement is acceleration of the development of a measles vector-based SARS-CoV-2 vaccine candidate.
  • MSD and IAVI, a nonprofit scientific research organization, announced a new collaboration to develop an investigational vaccine against SARS-CoV-2 to be used for the prevention of COVID-19.